Image

Neoadjuvant Chemotherapy for Locally Advanced Gall Bladder Cancer : a Randomized Control Trial (NEOGB)

Neoadjuvant Chemotherapy for Locally Advanced Gall Bladder Cancer : a Randomized Control Trial (NEOGB)

Recruiting
18-70 years
All
Phase 3

Powered by AI

Overview

to study role of chemotherapy treatment for gall bladder cancer before surgery as compared to surgery directly

Description

Gallbladder cancer is a highly aggressive disease with a late presentation and poor prognosis. Complete surgical excision remains the only potentially curative treatment for early-stage gallbladder cancer.

The use and benefit of chemotherapy in gallbladder cancer before surgery , that is , in the neoadjuvant setting, is not well studied and, to our knowledge, neoadjuvant chemotherapy has not been evaluated in any randomized clinical trial.

Neoadjuvant chemotherapy aims to achieve tumor downstaging, increase the radical surgical resection rate, reduce metastases. This study will compare the effectiveness of chemotherapy before surgery in locally advanced gall bladder cancer versus upfront surgery with respect to survival and completeness of resection of disease.

Eligibility

Inclusion Criteria:

  • ECOG 0-2
  • Locally advanced resectable GBC defined as Clinical T3/4 disease or Regional LN involvement on imaging studies.
  • Post cholecystectomy GBC with residual disease on imaging, History of bile spillage during primary surgery , history of piece-meal removal of gall bladder during simple cholecystectomy, Regional LN involvement on imaging studies.

Exclusion Criteria:

  1. Early GBC ( cT1/T2) without significant lymphadenopathy or liver infiltration on radiological imaging .
  2. Locally advanced disease requiring major hepatectomy or whipple's pancreatoduodenectomy.
  3. Post cholecystectomy GBC without any evidence of spillage of residual disease on radiological imaging.
  4. Obstructive jaundice due to involvement of biliary tree by tumour.
  5. Vascular involvement such as common hepatic artery, MPV right hepatic artery or right portal vein.
  6. Any distant metastasis or isolated port site metastasis
  7. Involvement of non-regional LN (e.g . Celiac LN, SMA lymph node, inter-aortocaval or left para-ortic LN).
  8. Poor performance status ECOG 3 or more.
  9. Pregnancy.
  10. Inability or unwillingness to follow study protocol

Study details
    Gall Bladder Carcinoma

NCT06712420

Rajiv Gandhi Cancer Institute & Research Center, India

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.